Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue
Aurobindo Pharma’s consolidated net profit for the quarter ended September rose 32.5% year-on-year (YoY) to ₹1,124 crore on higher revenue across markets and business segments. The profit came on a 24% increase in revenue from operations to ₹10,263 crore. It is the highest ever quarterly revenue thus far and driven by growth across businesses. The…
Read More “Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue” »